Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
BIOSerenity logo — Where AI meets brainwaves to redefine patient care. AI-assis...

BIOSerenity

Where AI meets brainwaves to redefine patient care. AI-assisted Electrophysiology Diagnostics

Founded 2014 France France 271 employees Series Unknown Total: $107.12M Health Care, Insurtech +1

General Information

Company Name BIOSerenity
Founded Year 2014
Location France France +1
Founders / Decision Makers
Team member
Employees 271
Industries Health Care, Insurtech, Medical Devices
Funding Stage Series Unknown
Social

Get notified when BIOSerenity moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Sep 02, 2026

BIOSerenity will participate in the Soirée EpiLor event in Nancy.

Get alerts when BIOSerenity shows new signals

About BIOSerenity

BIOSerenity, founded in 2014 and headquartered in Paris, France, offers groundbreaking solutions within the Health Care, Insurtech, and Medical Devices industries. Their slogan, "Connected & integrated neurosciences. Brain monitoring & remote diagnostic," succinctly captures the company's mission to advance the monitoring and diagnosis of patients with chronic neurological, sleep, and cardiovascular conditions.

Utilizing a suite of physiological sensors, an IoT platform, apps, and A.I., BIOSerenity identifies digital biomarkers, partnering with over 200 hospitals across Europe to facilitate the diagnosis of more than 100,000 patients annually.

In its latest round of funding, the company secured a €24.00M investment from Jolt Capital on 13 November 2023. This injection of capital denotes confidence in BIOSerenity's potential, bolstering their innovative approach towards revolutionizing patient care in chronic disease management.

Taxonomy: Connected Medical Solutions, Chronic Disease Diagnostics, Neurology, Sleep Disorders, Cardiology, Physiological Sensors, IoT Platform, Digital Biomarkers, AI in Healthcare, Remote Diagnostics, Smart Clothing, Mobile Diagnostics, EEG, Polysomnography, Research Collaboration

Services & Products

EEG Monitoring and Diagnostics
Sleep Disorder Management
AI and Software Solutions for Hospitals
Connected EEG Devices

Target Customers

Hospitals Medical Facilities Specialist Doctors Healthcare Providers Patients with Neurological Disorders

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
13 Nov 2023
Corporate Round •••••• 1
Investor
17 Feb 2022
Corporate Round •••••• 1
Investor
05 Nov 2019
Series B •••••• 4
Investor Investor Investor
•••• •••• 		19 Jun 2019
Series A •••••• 4
Investor Investor Investor Investor
20 Sep 2017

View All 7 Funding Rounds

BIOSerenity Alternatives & Competitors

View All Alternatives
BIOSerenity vs
Veracyte, Inc.
Veracyte, Inc. United States

Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc.

IPO
748 employees
Biotechnology, Health Care
Compare BIOSerenity vs Veracyte, Inc.
BIOSerenity vs
Medi-Lynx Cardiac Monitoring, LLC
Medi-Lynx Cardiac Monitoring, LLC United States

Delivering confidence in your next steps of care.

102 employees
Health Care
Compare BIOSerenity vs Medi-Lynx Cardiac Monitoring, LLC
BIOSerenity vs
PainScan
PainScan United States

PainScan displays pain in 3D so doctors can more effectively diagnose and treat their patients

Grant
2 employees
Health Care, Medical Devices
Compare BIOSerenity vs PainScan
View all alternatives

FAQ About BIOSerenity

Where AI meets brainwaves to redefine patient care. AI-assisted Electrophysiology Diagnostics
BIOSerenity was founded in 2014.
BIOSerenity is headquartered in France.
BIOSerenity operates in the following industries: Health Care, Insurtech, Medical Devices.
BIOSerenity has approximately 271 employees.
BIOSerenity has completed 7 funding rounds, raising a total of $107.12M. The latest funding stage is Series Unknown.
BIOSerenity offers: EEG Monitoring and Diagnostics, Sleep Disorder Management, AI and Software Solutions for Hospitals, Connected EEG Devices.
Top alternatives and competitors to BIOSerenity include Veracyte, Inc., Medi-Lynx Cardiac Monitoring, LLC, PainScan, xMD Diagnostics, Inc., Inherent Biosciences, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BIOSerenity and Veracyte, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BIOSerenity and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy